Welcome to Axiogenesis iPSC-derived cells and assays
Axiogenesis is a leading provider of commercial-grade in vitro differentiated cells (e.g., cardiac, neuronal) derived from human induced pluripotent stem cells (iPSCs), along with validated assays, which enable drug development. Assays for each cell type have been developed for advanced drug discovery, safety pharmacology / in vitro toxicology, and disease / tissue modeling. Our innovative and proprietary cell types and assays accelerate and improve drug candidate selection, lower costs and thus increase overall drug development efficiency.
Brands: Cor.4U, Peri.4U, Dopa.4U, CNS.4U, CorV.4U, FibroCor.4U, Astro.4U